FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage
- PMID: 33977480
- DOI: 10.1007/978-1-0716-1190-6_13
FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage
Abstract
On the plasma membrane, Ras is organized into laterally segregated proteo-lipid complexes called nanoclusters. The extent of Ras nanoclustering correlates with its signaling output, positioning nanocluster as dynamic signaling gain modulators. Recent evidence suggests that stacked dimers of Ras and Raf are elemental units at least of one type of Ras nanocluster. However, it is still incompletely understood, in which physiological contexts nanoclustering is regulated and which constituents are parts of nanocluster. Nonetheless, disruption of nanoclustering faithfully diminishes Ras activity in cells, suggesting Ras nanocluster as potential drug targets.While there are several methods available to study Ras nanocluster , fluorescence or Förster resonance energy transfer (FRET ) between fluorescently labeled, nanoclustered Ras proteins is a relatively simple readout. FRET measurements using fluorescence lifetime imaging microscopy (FLIM ) have proven to be robust and sensitive to determine Ras nanoclustering changes. Loss of FRET that emerges due to nanoclustering reports on all processes upstream of Ras nanoclustering, i.e., also on proper trafficking or lipid modification of Ras. Here we report our standard FLIM-FRET protocol to measure nanoclustering-dependent FRET of Ras in mammalian cells. Importantly, nanoclustering-dependent FRET is one of the few methods that can detect differences between the Ras isoforms.
Keywords: FLIM; FRET; GTPase; Nanocluster; Plasma membrane; Ras.
Similar articles
-
Detection of Ras nanoclustering-dependent homo-FRET using fluorescence anisotropy measurements.Eur J Cell Biol. 2023 Jun;102(2):151314. doi: 10.1016/j.ejcb.2023.151314. Epub 2023 Apr 11. Eur J Cell Biol. 2023. PMID: 37058825
-
The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering.J Biol Chem. 2014 Apr 4;289(14):9519-33. doi: 10.1074/jbc.M113.537001. Epub 2014 Feb 25. J Biol Chem. 2014. PMID: 24569991 Free PMC article.
-
Super-Resolution Imaging and Spatial Analysis of RAS on Intact Plasma Membrane Sheets.Methods Mol Biol. 2021;2262:217-232. doi: 10.1007/978-1-0716-1190-6_12. Methods Mol Biol. 2021. PMID: 33977479 Free PMC article.
-
Nanoclustering as a dominant feature of plasma membrane organization.J Cell Sci. 2014 Dec 1;127(Pt 23):4995-5005. doi: 10.1242/jcs.146340. J Cell Sci. 2014. PMID: 25453114 Free PMC article. Review.
-
Drug targeting opportunities en route to Ras nanoclusters.Adv Cancer Res. 2022;153:63-99. doi: 10.1016/bs.acr.2021.07.005. Epub 2021 Aug 20. Adv Cancer Res. 2022. PMID: 35101236 Review.
Cited by
-
Membrane-Driven Dimerization of the Peripheral Membrane Protein KRAS: Implications for Downstream Signaling.Int J Mol Sci. 2024 Feb 21;25(5):2530. doi: 10.3390/ijms25052530. Int J Mol Sci. 2024. PMID: 38473778 Free PMC article. Review.
-
FLIM-FRET Protein-Protein Interaction Assay.Methods Mol Biol. 2024;2797:261-269. doi: 10.1007/978-1-0716-3822-4_19. Methods Mol Biol. 2024. PMID: 38570466
-
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth.J Med Chem. 2024 Jun 13;67(11):8569-8584. doi: 10.1021/acs.jmedchem.3c02129. Epub 2024 May 17. J Med Chem. 2024. PMID: 38758695 Free PMC article.
-
Protocol to measure and analyze protein interactions in mammalian cells using bioluminescence resonance energy transfer.STAR Protoc. 2024 Dec 20;5(4):103348. doi: 10.1016/j.xpro.2024.103348. Epub 2024 Sep 28. STAR Protoc. 2024. PMID: 39342617 Free PMC article.
-
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane.iScience. 2022 Oct 9;25(11):105282. doi: 10.1016/j.isci.2022.105282. eCollection 2022 Nov 18. iScience. 2022. PMID: 36304112 Free PMC article.
References
-
- Stephen AG, Esposito D, Bagni RK, McCormick F (2014) Dragging Ras back in the ring. Cancer Cell 25:272–281. https://doi.org/10.1016/j.ccr.2014.02.017 - DOI - PubMed
-
- Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, Gaida K, Holt T, Knutson CG, Koppada N, Lanman BA, Werner J, Rapaport AS, Miguel TS, Ortiz R, Osgood T, Sun J-R, Zhu X, McCarter JD, Volak LP, Houk BE, Fakih MG, O’Neil BH, Price TJ, Falchook GS, Desai J, Kuo J, Govindan R, Hong DS, Ouyang W, Henary H, Arvedson T, Cee VJ, Lipford JR (2019) The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575:1–26. https://doi.org/10.1038/s41586-019-1694-1 - DOI
-
- Schmick M, Vartak N, Papke B, Kovacevic M, Truxius DC, Rossmannek L, Bastiaens PIH (2014) KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport. Cell 157:459–471. https://doi.org/10.1016/j.cell.2014.02.051 - DOI - PubMed
-
- Rocks O, Gerauer M, Vartak N, Koch S, Huang Z-P, Pechlivanis M, Kuhlmann J, Brunsveld L, Chandra A, Ellinger B, Waldmann H, Bastiaens PIH (2010) The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell 141:458–471. https://doi.org/10.1016/j.cell.2010.04.007 - DOI - PubMed
-
- Ahearn IM, Haigis K, Bar-Sagi D, Philips MR (2012) Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol 13:39–51. https://doi.org/10.1038/nrm3255 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous